Screening for Residual Disease in Pediatric Burkitt Lymphoma Using Consensus Primer Pools

Assessing molecular persistent or minimal residual disease (PD/MRD) in childhood Burkitt lymphoma (BL) is challenging because access to original tumor is usually needed to design patient-specific primers (PSPs). Because BL is characterized by rearranged immunoglobulin heavy chain (IgV(H)) genes, IgV...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Agsalda, Melissa, Kusao, Ian, Troelstrup, David, Shiramizu, Bruce
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2009
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771857/
https://ncbi.nlm.nih.gov/pubmed/19890467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/412163
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia